|
||
|
| Home |  |
Firm Description | |
Sectors Covered | |
Completed Transactions | |
Testimonials | |
Principals | |
M&A Report and Publications |
|
Contact Us | |
| Acquiring Party | Datascope Corp. (NASDAQ: DSCP), a diversified medical device company that manufactures proprietary products for interventional cardiology and radiology, cardiovascular and vascular surgery, anesthesiology, emergency medicine and critical care. |
|---|---|
| Transferring Party | CardioVations endoscopic vessel harvesting line of Ethicon, Inc., a unit of J&J. |
| Sector | Medical Devices |
| Date | December 30, 2005 |
| Analysis A complementary product line for Datascope. This $3.25mm deal is contingent on the Guidant/J&J deal closing. The CardioVations unit had about $13mm in sales. | |
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. This information is copyright © 2004-2010 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. | |